Medicinal composition for treating primary liver cancer

Abstract

The invention provides a minority traditional Chinese medicinal prescription capable of inhibiting liver cancer, which realizes comprehensive regulation aiming at the pathogenesis of liver cancer. On the basis of the Guangxi Zhuang nationality folk medicine, the inventor studies the traditional Zhuang nationality medicine theory and the traditional Chinese medicine theory, and the long-term clinical application verification shows that the medicinal composition has the good treatment effects. A composition is prepared from the following medicinal materials in parts by weight: 10-15 parts of rhizoma curcumae from Guangxi, 20-30 parts of herba hedyotis diffusae, 15-30 parts of radix corydalis thalictrifoliae, 15-30 parts of fiveleaf gynostemma herb, 6-12 parts of radix bupleuri, 15-30 parts of radix codonopsis, 15-30 parts of semen coicis, and 3-10 parts of leeches.

Description

technical field [0001] The invention relates to a pharmaceutical composition, especially a pharmaceutical composition for treating primary liver cancer. Background technique [0002] Primary hepatocellular carcinoma (hepatocellular carcinoma, HCC, hereinafter referred to as liver cancer) is a common malignant tumor. The characteristics of high metastasis and easy recurrence are important reasons for the high mortality rate of patients and seriously endanger human health. There are about 620,000 new cases of liver cancer in the world every year, 55% of which are in my country, and the incidence rate is about 30.3 / 100,000. About 140,000 people die of primary liver cancer every year [1] . [0003] At present, it is believed that the occurrence and development of liver cancer is a complex process of interaction between genetic and environmental factors, multi-inducement, multi-gene participation, and multi-step regulation. Modern Chinese medicine believes that liver cancer is ...

AI Technical Summary

Problems solved by technology

However, some prescriptions are more complicated, some are only in the experimental stage, the application time is short, and no experimental research has been carried out. Clinically, no large-scale clinical research has been carried out, and clinical verification is still awaited.

Images